Perspectives bone histomorphometry in glucocorticoid‐induced osteoporosis

Journal of Bone and Mineral Research

Volumn 4, Issue 2, 1989, Pages 137-141

  Dempster, David W ^a,b  

^a NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; CALCITRIOL; CALCIUM; FLUORIDE SODIUM; GLUCOCORTICOID; PAMIDRONIC ACID;

BONE; HISTOMETRY; HUMAN; OSTEOPOROSIS; REVIEW;

BONE AND BONES; FEMALE; GLUCOCORTICOIDS; HUMAN; OSTEOPOROSIS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024554774     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.5650040202     Document Type: Article

References (50)

1. Effect of hormone of adrenal cortex (compound E) and pituitary adrenocorticotropic hormone on rheumatoid arthritis
2. Corticosteroids and osteoporosis
3. Bone histomorphometry: Standardization of nomenclature, symbols, and units
4. Corticosteroid osteoporosis
5. Histomorphometric profile, pathophysiology and reversibility of corticosteroid‐induced osteoporosis
6. Altered mineral metabolism in glucocorticoid‐induced osteopenia: Effect of 25‐hydroxyvitamin D administration
7. Bone mineral loss, bone histomorphometry and vitamin D metabolism in patients with rheumatoid arthritis on long‐term glucocorticoid treatment
8. Bone loss in autoimmune chronic active hepatitis on maintenance corticosteroid therapy
9. Physiological senile involution and pathological rarefaction of bone
10. Glucocorticoid osteoporosis: A longitudinal study
11. Glucocorticoid‐induced osteoporosis
12. Effects of chronic corticosteroid therapy on mineral metabolism and calcium absorption
13. Bone tissue mechanisms underlying osteoporoses
14. 3 administration on bone and bone mineral metabolism in patients on chronic glucocorticoid treatment; a double blind controlled study
15. Pathophysiology of the adverse effects of glucoactive corticosteroids on calcium metabolism in man
16. Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans
17. Drug‐induced disorders of vitamin D and mineral metabolism
18. The effects of hydrocortisone, parathyroid hormone and the bisphosphonate, APD, on bone resorption in neonatal mouse cal varia
19. 45Ca release from embryonic rat bone in vitro
20. Corticosteroid and bone
21. Endocrine influences on bone cells and bone remodeling evaluated by clinical histomorphometry
22. Estimation of trabecular bone resorption by histomorphometry: Evidence for a prolonged reversal phase with normal resorption in post‐menopausal osteoporosis and coupled increased resorption in primary hyperparathyroidism
23. The effect of cortisone on lamellar osteoblastic activity
24. Bone formation in hypercortisonism
25. Bone histomorphometry and structure in corticosteroid‐treated active hepatitis
26. Mean wall thickness and formation periods of trabecular bone packets in corticosteroid‐induced osteoporosis
27. Bone histomorphometry in corticosteroid‐induced osteoporosis and Cushing's syndrome
28. Glucocorticoid receptors and inhibition of bone cell growth in primary culture
29. Detection of high affinity glucocorticoid binding in rat bone
30. Glucocorticoid receptor in clonal osteosarcoma cell lines: A novel system for investigating bone active hormones
31. Effects of glucocorticoids on fetal rat bone collagen synthesis in vitro
32. Serum osteocalcin is increased in patients with hyperthyroidism and decreased in patients receiving glucocorticoids
33. Low serum osteocalcin levels in glucocorticoid‐treated asthmatics
34. Biochemical markers of bone turnover in osteoporosis
35. Glucocorticoid‐induced osteoporosis
36. Trabecular bone architecture in the pathogenesis and prevention of fracture
37. A simple method for correlative light and scanning electron microscopy of human iliac crest bone biopsies: Qualitative observations in normal and osteoporotic subjects
38. Recovery from steroid‐induced osteoporosis
39. Disorders of the adrenal cortex
40. Effect of oral 1,25‐dihydroxyvitamin D and calcium on glucocorticoid‐induced osteopenia in patients with rheumatic diseases
41. Prevention of steroid‐induced osteoporosis with (3‐amino‐1‐hydroxypropylidene)‐1,1‐bisphosphonate (APD)
42. Traitement de l'osteoporose cortisonique par le fluorore de sodium: Effets cliniques et donnees histomorphometriques. Ann. Endocrinol
43. Treatment with fluoride: Bone histomorphometric findings
44. Bone disease in rheumatoid arthritis
45. Determining causation—a case study: Adrenocorticosteroids and osteoporosis. Should the fear of inducing clinically important osteoporosis influence the decision to prescribe adrenocorticosteroids?
46. Osteoporosis in rheumatoid arthritis
47. Bone histomorphometry: Analysis of trabecular bone dynamics
48. Normal and pathological remodeling of human trabecular bone: Three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease
49. Bone loss after glucocorticoid therapy